We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 283

Upcoming INSPECT Compliance Dates
  • Krieg DeVault
  • USA
  • October 29 2018

Governor Eric Holcomb signed Senate Enrolled Act 221 (“SEA 221”) into law on March 22, 2018, which updated INSPECT requirements for practitioners


HIPAA and the Opioid Crisis
  • Dickinson Wright
  • USA
  • August 22 2018

With the ever-growing opioid crisis and the President’s call to action to address that crisis, primary care, pain management and behavioral health


The Future of Percutaneous Vertebroplasty; A Crack in the Cement?
  • Bolt Burdon Kemp
  • United Kingdom
  • July 2 2018

Percutaneous vertebroplasty is a routine procedure commonly employed to treat painful spinal fractures, particularly those caused as a result of


Expanded Certificate of Need Exemptions Poised to Grow Healthcare Industry
  • McBrayer McGinnis Leslie & Kirkland PLLC
  • USA
  • June 28 2018

In recent months, the Commonwealth of Kentucky has begun to amend the Kentucky Administrative Regulations and the Kentucky Revised Statutes, aiming to


Washington Healthcare Update - Jun 18, 2018
  • McGuireWoods LLP
  • USA
  • June 18 2018

The House began its two-week vote-a-thon on opioid legislation. On June 12, the house passed 25 bills and continued to work on opioid legislation


Averting Government Scrutiny in the Wake of an Opioid Prescribing Crackdown
  • Bradley Arant Boult Cummings LLP
  • USA
  • June 15 2018

The scourge of opioid-related addiction and risk is a well-known story among the pain management community. In response to this federally declared


House Passes 12 Bills Aimed at Combating Opioid Crisis
  • Quarles & Brady LLP
  • USA
  • June 13 2018

On Tuesday, the House of Representatives passed a fleet of bills aimed at combating the ongoing opioid crisis, most aimed at developing preventative


Boots on the Ground: PIL Task Force Targeting Opioid Providers in the War on Drugs
  • K&L Gates
  • USA
  • April 30 2018

Attorney General Jeff Sessions announced the creation of the Prescription Interdiction & Litigation (“PIL”) Task Force -- which Sessions described as


Medicare Opioid Prescribing Rates Vary Widely Across the U.S.
  • Manatt Phelps & Phillips LLP
  • USA
  • April 23 2018

In 2016, 11.5 million people in the United States misused prescription opioids, and more than 42,000 people died from an opioid overdose. One factor


Opioid Crisis Proposals and Funding
  • Holland & Knight LLP
  • USA, United Kingdom
  • April 9 2018

In 2016, through the Comprehensive Addiction and Recovery Act (CARA) and the 21st Century Cures Act, Congress authorized roughly $1.4 billion in